TPST · Tempest Therapeutics, Inc.
$0.92
+0.01 (+1.58%)
At close · Aug 7
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our need for additional capital to fund our planned programs and operations and to continue to operate as a going concern”View the 10-Q filed May 14, 2026
Market Cap
$13.36M
Shares
14.81M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-06-20 | $14,500,000 | $11,600,000 | 2025-09-30 | — | 10-Q , filed 2025-11-05 |